Rehab.ai-funded research · Recruiting researchers and treatment centers
More resources for care. Better outcomes for people.
Behavioral Health Advertising & Care Study
Rehab.ai is funding a study to measure advertising costs across addiction treatment and mental health care, and determine how more of those resources can support providers, lower costs for patients and families, and fund treatment directly.
Every dollar spent reaching someone should be examined against what it could do to help them.
A better system makes it easier for people to find care and for providers to deliver it. We are putting resources behind that goal: trace the spending, measure what it delivers, and identify where a different approach can do more for the people seeking help.
Our mission brings together data, technology, and human connection. This study extends it from how people discover treatment to how the resources behind that discovery are used.
By the numbers
The stakes are measurable.
$558.8M
Advertising and marketing
BetterHelp’s 2024 segment expense, excluding stock-based compensation, as reported by Teladoc Health. This includes more than media purchases. [1]
29.5M
Adults without treatment
U.S. adults with a past-year mental illness who received no mental health treatment in 2024, according to SAMHSA. [2]
65.2%
Cost was a concern
Among U.S. adults with past-year mental illness, no treatment, and a perceived unmet need in 2024, this share said treatment would cost too much. [2]
The spending figure describes one business segment, not the industry. The survey figures describe U.S. adults. These are context for the study, not evidence that advertising caused the treatment gap or that all marketing spending can be redirected.
Join the study.
Apply to lead the research or register your treatment center’s interest. Our team will follow up to discuss fit, scope, and next steps.
Sources and perspective
Teladoc Health 2024 Annual Report, BetterHelp segment results, pp. 67–68. Historical 2024 benchmark; advertising and marketing expense excludes stock-based compensation.
World Health Organization, Mental health at work. The US$1 trillion estimate concerns annual global productivity losses from depression and anxiety, not treatment spending or recoverable advertising dollars.